Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • IVIG:Intravenous Immunoglobulins in the treatment of COVID-19

ACTREC Scientific Assistant Recruitment | Biotechnology | Life Sciences

Fetus in Fetu analysis by modern Multimode Ultrasound

IVIG:Intravenous Immunoglobulins in the treatment of COVID-19
  • BiotechToday
  • World

IVIG:Intravenous Immunoglobulins in the treatment of COVID-19

bioxone October 21, 2020October 21, 2020

Binayak Das, Team Bioxone

A study conducted to unravel the potential of immunotherapy for patients affected by the covid-19 virus has announced that treatment with intravenous-immunoglobulin can potentially benefit covid-19 patients that are severely affected.

Intravenous immunoglobulin or IVIG is the collection of IgG obtained from the blood serum of a large number of healthy donors. It is one of the most widely sought-after immunotherapeutic molecules that has depicted the ability to cure autoimmune and inflammatory disorders to a large extent. The therapeutic advantage of IVIG over the use of powerful drugs and steroids in immunotherapies is that it targets multiple underlying mechanisms that are mutually non-exclusive. It even can target cellular mediators that are associated with immune response.

A cohort study reported the viability of IVIG as a treatment measure for severely affected COVID-19 individuals. The authors of that study administered IVIG to one half (174 patients) of the total pool (325) of affected individuals that were admitted to hospitals in southern China. They later inferred that the population that received IVIG early on (≤ 7 days after admission) and in high dosage (>15g per day) showed better prognosis than the ones that didn’t receive it.

The presence of limitations like varying duration of treatment and other parameters that varied with different hospitals rendered difficulty in extrapolating the full spectrum of this treatment. The authors mentioned that placebo-controlled clinical observations were extremely necessary for the successful evaluation of the IVIG treatment of COVID-19 treatment. And also said that a minimum of 2g kg-1 of dosage of IVIG would be necessary for conducting further clinical trials. 

Although certain reports have claimed the administration of the combination of corticosteroids with IVIG to have resulted in a more progressive anti-inflammatory manifestation in critical patients, that would again make the individual contribution of IVIG to be unclear.

The authors stated that they are certain that better outcome was always observed amongst cases where IVIG treatment was coupled with steroids. And concluded by stating that further studies are deemed necessary for accurate knowledge on the effectivity and clarity in the viability of the use of IVIGs in immunotherapies aimed at treating individuals with the coronavirus-19 disease. 

Also read: Multiple Antibody Panel to treat Esophageal Squamous Cell Carcinoma (ESCC)

Sources: 

  1. Galeotti, Caroline, et al. “Intravenous Immunoglobulin Immunotherapy for Coronavirus Disease‐19 (COVID‐19).” Clinical & Translational Immunology, vol. 9, no. 10, Jan. 2020. DOI:10.1002/cti2.1198
  2. Shao, Z., Feng, Y., Zhong, L., Xie, Q., Lei, M., Liu, Z., Wang, C., Ji, J., Liu, H., Gu, Z., Hu, Z., Su, L., Wu, M., & Liu, Z. (2020). Clinical efficacy of intravenous immunoglobulin therapy in critically ill patients with COVID‐19: A multicenter retrospective cohort study. Clinical & Translational Immunology, 9(10). https://doi.org/10.1002/cti2.1192
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged anti-inflammatory CORONAVIRUS corticosteroids COVID-19 drugs IgG Immunotherapy intravenous immunoglobulins IVIG SARS-CoV-2

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Fetus in Fetu analysis by modern Multimode Ultrasound

bioxone October 22, 2020

Souradip Mallick, National Institute of Technology, Rourkela Fetus in fetu (FIF) has been defined as the presence of one of the twins in the body of the other. It is a condition in which malformed and parasitic fetus is located in the body of the normal fetus. It is very difficult for the radiologist to […]

Fetus

Related Post

  • BiotechToday
  • World

The universe expansion: New theories proposed!

BioTech Today January 25, 2022January 25, 2022

Rutuja M. Borawke, M.E.S. Abasaheb Garware College, Pune Scientists from Physical Research Laboratory (PRL), Ahmedabad & IISc Bangalore have compiled research that focuses on examining the driving force for expanding the universe & the nature of dark energy. Mohanty from PRL clears the fact that only 5% of the universe is understood. The remaining is […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Prostate cancer: New insights into its therapeutic treatment

BioTech Today September 4, 2021September 4, 2021

Aqsa, Jamia Millia Islamia The Prostate Gland The prostate is a gland found in men. It is situated just below the bladder or in front of the large part of the rectum. It wraps around the part of the urethra that passes urine and semen out of the body. What is Prostate Cancer? Prostate cancer […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Genetically modified mosquitoes to control the Zika virus?

bioxone February 4, 2021February 4, 2021

Prama Ghosh, Amity University Kolkata The Zika virus epidemic was a public health emergency, causing birth defects for pregnant women in addition to neurological problems. The virus gets transmitted to humans from female mosquito bites. Researchers have tried several techniques to eliminate the spread of the virus, one of which is the use of genetically […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy